XyloCore

AIFA formalises the XyloCore compassionate use programme and inclusion in the national registry

 Home Dialysis Research Day

Dr Arduino Arduini invited by the University of Sheffield and the UK Kidney Foundation to participate as a speaker at the Home Dialysis Research Day for an update on the ELIXIR clinical trial

Phase III “ELIXIR” Publication

Publication of the design of the Phase III multicentre clinical trial 'ELIXIR' in the leading peritoneal dialysis journal 'Peritoneal Dialysis International'

Editorial on the ELIXIR clinical trial

Encouraging editorial by Dr Johann Morelle (University Hospitals Namur, Namur, Belgium) and Dr Carl M. Öberg (Lund University, Lund, Sweden) on our ELIXIR clinical trial

Publication in an international journal

Publication of the design of the Phase II multicentre clinical trial 'PURE' in the international journal 'Kidney and Blood Pressure Research' 

Television interview on the LEADER program

Television program hosted by Marco Columbro.
Studio guest: Dr. Arduini

Iperboreal Pharma
on  Instagram

Scientific publication

In collaboration with Italian nephrologists, a scientific publication on the biocompatibility of peritoneal dialysis solutions

Approval of PURE study in Italy

Approval of PURE study in Italy (Phase II - PolyCore for refractory congestive heart failure)

Approval of the ASTRA study

Approval of the ASTRA study in Italy (Phase III - Glucothera Plus for end-stage kidney disease – paediatric patients)

Approval of ELIXIR study

Approval of ELIXIR study in ITA, ESP, GER, DK, SVE, UK (Phase III – XyloCore for end-stage kidney disease)